LAIR-1 limits macrophage activation in acute inflammatory lung injury.

[1]  H. Tao,et al.  The Role of Macrophages and Alveolar Epithelial Cells in the Development of ARDS , 2022, Inflammation.

[2]  Lixin Xie,et al.  Progress in preclinical studies of macrophage autophagy in the regulation of ALI/ARDS , 2022, Frontiers in Immunology.

[3]  A. Sharpe,et al.  Human PD-1 agonist treatment alleviates neutrophilic asthma by reprogramming T cells. , 2022, The Journal of allergy and clinical immunology.

[4]  Myoungsun Son.  Understanding the contextual functions of C1q and LAIR-1 and their applications , 2022, Experimental & Molecular Medicine.

[5]  C. Burger,et al.  The Role of Immune Checkpoint Molecules on Macrophages in Cancer, Infection, and Autoimmune Pathologies , 2022, Frontiers in Immunology.

[6]  O. Akbari,et al.  Autophagy impairment in liver CD11c+ cells promotes non-alcoholic fatty liver disease through production of IL-23 , 2022, Nature Communications.

[7]  C. E. Perlman,et al.  Update on the Features and Measurements of Experimental Acute Lung Injury in Animals: An Official American Thoracic Society Workshop Report , 2022, American journal of respiratory cell and molecular biology.

[8]  T. Plösch,et al.  LPS versus Poly I:C model: comparison of long-term effects of bacterial and viral maternal immune activation on the offspring , 2021, American journal of physiology. Regulatory, integrative and comparative physiology.

[9]  Ramezan Jafari,et al.  Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management , 2021, Pneumonia.

[10]  O. Akbari,et al.  Cannabinoid Receptor II engagement promotes ILC2 expansion and enhances ILC2-dependent airway hyperreactivity. , 2021, The Journal of allergy and clinical immunology.

[11]  Samantha M. Carlisle,et al.  Homeostatic functions of monocytes and interstitial lung macrophages are regulated via collagen domain-binding receptor LAIR1. , 2021, Immunity.

[12]  N. Meyer,et al.  Acute respiratory distress syndrome , 2021, The Lancet.

[13]  O. Akbari,et al.  LAIR-1 acts as an immune checkpoint on activated ILC2s and regulates the induction of airway hyperreactivity. , 2021, The Journal of allergy and clinical immunology.

[14]  André F. Rendeiro,et al.  A molecular single-cell lung atlas of lethal COVID-19 , 2021, Nature.

[15]  Sinead E. Morris,et al.  Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19 , 2021, Immunity.

[16]  Mark S. Anderson,et al.  Longitudinal single-cell epitope and RNA-sequencing reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19 , 2021, bioRxiv.

[17]  Z. Dong,et al.  Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model , 2021, Frontiers in Immunology.

[18]  C. Lam,et al.  Interleukin-38 ameliorates poly(I:C) induced lung inflammation: therapeutic implications in respiratory viral infections , 2021, Cell death & disease.

[19]  A. Soubani,et al.  Management of ARDS – What Works and What Does Not , 2020, The American Journal of the Medical Sciences.

[20]  S. Bohlson,et al.  Extracellular signal-regulated kinase 1/2 is required for complement component C1q and fibronectin dependent enhancement of Fcγ- receptor mediated phagocytosis in mouse and human cells , 2020, BMC Immunology.

[21]  A. Artigas,et al.  Comparison of direct and indirect models of early induced acute lung injury , 2020, Intensive Care Medicine Experimental.

[22]  W. Marut,et al.  Leukocyte Associated Immunoglobulin Like Receptor 1 Regulation and Function on Monocytes and Dendritic Cells During Inflammation , 2020, Frontiers in Immunology.

[23]  A. Sharpe,et al.  PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity , 2020, Nature Communications.

[24]  B. Singer,et al.  Pathogenesis of COVID-19-induced ARDS: implications for an ageing population , 2020, European Respiratory Journal.

[25]  H. Merchant,et al.  Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis , 2020, Expert review of respiratory medicine.

[26]  A. Gasbarrini,et al.  Increased CD95 (Fas) and PD‐1 expression in peripheral blood T lymphocytes in COVID‐19 patients , 2020, British journal of haematology.

[27]  J. Luan,et al.  Role and mechanism of LAIR-1 in the development of autoimmune diseases, tumors, and malaria: A review. , 2020, Current research in translational medicine.

[28]  Xu-xin Chen,et al.  Macrophage polarization and its role in the pathogenesis of acute lung injury/acute respiratory distress syndrome , 2020, Inflammation Research.

[29]  Fugen Shangguan,et al.  LAIR-1 suppresses cell growth of ovarian cancer cell via the PI3K-AKT-mTOR pathway , 2020, Aging.

[30]  J. Borghans,et al.  Functional categories of immune inhibitory receptors , 2020, Nature Reviews Immunology.

[31]  I. Amit,et al.  Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19 , 2020, Nature Medicine.

[32]  Bo Diao,et al.  Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19) , 2020, Frontiers in Immunology.

[33]  A. Kang,et al.  Leukocyte-associated immunoglobulin-like receptor 1 inhibits T-cell signaling by decreasing protein phosphorylation in the T-cell signaling pathway , 2020, The Journal of Biological Chemistry.

[34]  M. Pallardy,et al.  Nrf2 downregulates zymosan-induced neutrophil activation and modulates migration , 2019, PloS one.

[35]  S. Watson,et al.  LAIR-1 Limits Neutrophilic Airway Inflammation , 2019, Front. Immunol..

[36]  Yan Li,et al.  TLR3 Regulated Poly I:C-Induced Neutrophil Extracellular Traps and Acute Lung Injury Partly Through p38 MAP Kinase , 2018, Front. Microbiol..

[37]  Q. Ma,et al.  LAIR-1 activation inhibits inflammatory macrophage phenotype in vitro. , 2018, Cellular immunology.

[38]  Mengtao Zhou,et al.  Involvement of the PI3K/Akt/NF-κB Signaling Pathway in the Attenuation of Severe Acute Pancreatitis-Associated Acute Lung Injury by Sedum sarmentosum Bunge Extract , 2017, BioMed research international.

[39]  A. Schuppert,et al.  Inflammatory processes during acute respiratory distress syndrome: a complex system , 2017, Current opinion in critical care.

[40]  Chengcai Lai,et al.  C-C Motif Chemokine Ligand 2 (CCL2) Mediates Acute Lung Injury Induced by Lethal Influenza H7N9 Virus , 2017, Front. Microbiol..

[41]  B. Volpe,et al.  Evidence for C1q-mediated crosslinking of CD33/LAIR-1 inhibitory immunoreceptors and biological control of CD33/LAIR-1 expression , 2017, Scientific Reports.

[42]  Xuning Wang,et al.  CXCL10/IP-10 Neutralization Can Ameliorate Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Rats , 2017, PloS one.

[43]  Li-yun Huang,et al.  Poly(I:C) Induces Human Lung Endothelial Barrier Dysfunction by Disrupting Tight Junction Expression of Claudin-5 , 2016, PloS one.

[44]  D. Brealey,et al.  Evidence for chemokine synergy during neutrophil migration in ARDS , 2016, Thorax.

[45]  M. Balaan,et al.  Acute Respiratory Distress Syndrome , 2016, Critical care nursing quarterly.

[46]  Anders Larsson,et al.  Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. , 2016, JAMA.

[47]  R. Lucas,et al.  The Acute Respiratory Distress Syndrome: Mechanisms and Perspective Therapeutic Approaches. , 2015, Austin journal of vascular medicine.

[48]  Zhigang Lu,et al.  The ITIM-containing receptor LAIR1 is essential for acute myeloid leukemia development , 2015, Nature Cell Biology.

[49]  H. Perlman,et al.  Flow cytometric analysis of macrophages and dendritic cell subsets in the mouse lung. , 2013, American journal of respiratory cell and molecular biology.

[50]  J. Schmid,et al.  The complexity of NF-κB signaling in inflammation and cancer , 2013, Molecular Cancer.

[51]  B. Cao,et al.  Monoclonal antibody against CXCL-10/IP-10 ameliorates influenza A (H1N1) virus induced acute lung injury , 2013, Cell Research.

[52]  R. Glenny,et al.  Mechanical ventilation modulates Toll-like receptor-3-induced lung inflammation via a MyD88-dependent, TLR4-independent pathway: a controlled animal study , 2010, BMC pulmonary medicine.

[53]  G. Matuschak,et al.  Acute lung injury and the acute respiratory distress syndrome: pathophysiology and treatment. , 2010, Missouri medicine.

[54]  T. Martin,et al.  Animal models of acute lung injury , 2008, American journal of physiology. Lung cellular and molecular physiology.

[55]  L. Meyaard.  The inhibitory collagen receptor LAIR‐1 (CD305) , 2008, Journal of leukocyte biology.

[56]  C. Geest,et al.  Differential expression of leukocyte‐associated Ig‐like receptor‐1 during neutrophil differentiation and activation , 2006, Journal of leukocyte biology.

[57]  L Meyaard,et al.  LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. , 1997, Immunity.

[58]  Y. Ding,et al.  The role of LAIR-1 (CD305) in T cells and monocytes/macrophages in patients with rheumatoid arthritis. , 2014, Cellular immunology.